NASUS PHARMA LTD. (NSRX) Net income 2023–2025
NASUS PHARMA LTD. (NSRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$5.9MFY2025 · since FY2023: -$1.1M → -$5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.9M | -282.2% |
| FY2024 | -$1.5M | -45.8% |
| FY2023 | -$1.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice